AMRX | Amneal Pharmaceuticals Inc 4.94 -0.11 (-2.19%)
Category: Consumer goods
Industry: Drug Manufacturers - Specialty & Generic Quick infos Headquarters: Bridgewater Township, New Jersey, United States Trade prices Volume: Market Cap: 831.15M Prev closed: Open: High: Low: 52 week low: 52 week high: Dividends: Next ER: February 26, 2021 Before Market Opens
Earnings History Date EPS / Forecast Revenue / Forecast May 18, 2021 February 26, 2021 0.14 / 0.1327510M / 506.04MBeat! November 6, 2020 0.16 / 0.1218519.29M / 482.16MBeat! August 6, 2020 0.13 / 0.1464.66M / 454.28MBeat! view more
Historical Data Date Price Open High Low Vol Change ER Feb 26, 2021 5.39 4.99 5.88
4.99
4.61M 10.22% Feb 25, 2021 4.89 5.05 5.14
4.87
1.30M -4.12% Feb 24, 2021 5.10 4.83 5.18
4.83
1.46M 6.25% Feb 23, 2021 4.80 5.36 5.38
4.73
3.00M -10.45% Feb 22, 2021 5.36 5.59 5.61
5.33
1.21M -4.8% Feb 19, 2021 5.63 5.59 5.70
5.55
674.11K 0% Feb 18, 2021 5.63 5.64 5.76
5.60
960.11K -0.53% Feb 17, 2021 5.66 5.54 5.68
5.48
1.17M 1.25% Feb 16, 2021 5.59 5.79 5.93
5.55
1.46M -2.27% Feb 12, 2021 5.72 5.84 5.87
5.70
751.43K -3.05% view more
News
Amneal to Report Third Quarter 2020 Results on November 6, 2020 finance.yahoo.com Mar 8, 2021 8:00 am
Recap: Amneal Pharmaceuticals Q3 Earnings finance.yahoo.com Mar 8, 2021 7:53 am
Amneal Pharmaceuticals (AMRX) Surpasses Q4 Earnings and Revenue Estimates finance.yahoo.com Mar 8, 2021 7:30 am
Amneal Pharmaceuticals, Inc. to Host Earnings Call finance.yahoo.com Mar 8, 2021 6:30 am
Amneal Receives Approval for Generic Version of Ortho Evra® finance.yahoo.com Mar 8, 2021 6:02 am
Amneal Posts Better-Than-Expected Q4 Results; Upbeat 2021 Revenue Outlook finance.yahoo.com Mar 1, 2021 10:39 am
A Preview Of Amneal Pharmaceuticals's Earnings finance.yahoo.com Feb 25, 2021 10:04 am
AMRX or CORT: Which Is the Better Value Stock Right Now? finance.yahoo.com Feb 10, 2021 11:40 am
Amneal Pharmaceuticals, Inc.'s (NYSE:AMRX) Intrinsic Value Is Potentially 96% Above Its Share Price finance.yahoo.com Feb 7, 2021 11:32 pm
AMRX or PCRX: Which Is the Better Value Stock Right Now? finance.yahoo.com Jan 15, 2021 11:40 am
Amneal Launches Generic Abiraterone Acetate Tablets, USP, 500 mg, Following ANDA Approval by FDA finance.yahoo.com Jan 8, 2021 8:00 am
21 Largest Generic Drug Companies finance.yahoo.com Dec 16, 2020 1:57 pm
Are Options Traders Betting on a Big Move in Amneal Pharmaceuticals (AMRX) Stock? finance.yahoo.com Dec 14, 2020 8:54 am
Should You Buy Amneal (AMRX) Ahead of Earnings? finance.yahoo.com Dec 14, 2020 8:51 am
Amneal Pharmaceuticals: Q1 Earnings Insights finance.yahoo.com Dec 14, 2020 8:43 am Lannett to cut jobs following FDA approval of competing generic drug marketwatch.com Dec 14, 2020 7:34 am
Top Pharmaceutical Stocks for Q1 2021 investopedia.com Dec 7, 2020 10:56 am
The Amneal Pharmaceuticals, Inc. (NYSE:AMRX) Third-Quarter Results Are Out And Analysts Have Published New Forecasts finance.yahoo.com Nov 10, 2020 5:09 am
Amneal (AMRX) Catches Eye: Stock Jumps 6.7% finance.yahoo.com Dec 14, 2020 8:42 am
Amneal to Report Second Quarter 2020 Results on August 6, 2020 finance.yahoo.com Dec 14, 2020 8:00 am Key Persons CEO : Chirag Patel (2019–), Chintu Patel (2019–) Talk about Amneal Pharmaceuticals Inc below in comments section below. Do you think you'll buy? Do you already have active trades now?
EarningsAhead is not affiliated with and this is not an endorsement of the companies featured above. This profile is based on publicly available information and is intended to be informative in nature. Most of the datas are collected by our Data Entry and we aim to be as accurate as humanly possible.
Share it with fellow traders:
or join discussions in FB below
(
FB comments )
If you are looking for News & events, Press Release, they are available on their Investors Relations site.
If you want to help pay for server cost or for improving this tool. You can send it via Paypal . More features coming soon :)
Buy on Amazon Graham's philosophy of "value investing" has made The Intelligent Investor the stock market bible ever since its original publication in 1949.
The best book on investing ever written. -- Warren Buffet